Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes
In this propensity score matched cohort, the use of RDV was associated with earlier patient reported symptom resolution during the PCC period, while there were no notable differences in functional outcomes. Our results indicate a possible beneficial effect of RDV in terms of faster symptom resolution after COVID19 infection.
Authors
- Enikő Bárczi (ORCID: https://orcid.org/0000-0001-9644-4172)
- Balázs Csoma (ORCID: https://orcid.org/0000-0002-9425-1219)
- Lőrinc Polivka (ORCID: https://orcid.org/0009-0004-9576-2776)
- Dorottya Fésü (ORCID: https://orcid.org/0000-0003-0428-703X)
- Gábor Horváth (ORCID: https://orcid.org/0000-0003-4079-1698)
- Szilvia Sebők
- Márton Boga (ORCID: https://orcid.org/0000-0002-1469-9460)
Institutions
- Semmelweis University (HU)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1186/s12879-024-10398-w
- Citations
- 3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Semmelweis Egyetem